AOD-9604
Peptide therapy: benefits, side effects, cost and protocols
AOD-9604 is a lipolytic 16-amino acid peptide fragment of human growth hormone, consisting of HGH residues 176-191. Initial human trials showed it retains the lipolytic properties of growth hormone without stimulating IGF-1 production. Its development was terminated in 2007 after later studies failed to demonstrate sufficient lipolytic effect.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Banned from Compounding March 2024 Removed from compounding nomination list. HGH fragment not eligible for compounding.
- Evidence
- Emerging Evidence
Who it's for
Who AOD-9604 is usually considered for
- Fat metabolism
- Lipolysis support
- Body composition
- Primarily animal or early-phase data
Mechanism
How AOD-9604 works
HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.
Evidence
Key studies
16 papers on PubMed
- 01
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
J Am Acad Orthop Surg Glob Res Rev
- 02
Therapeutic peptides reviewed for orthopaedic applications and future directions
- 03
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls
J Pharm Biomed Anal
- 04
Review of analytical methods for detecting emerging therapeutics and non-approved drugs in doping controls
- 05
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions
Expert Rev Proteomics / Expert Rev Proteomics
- 06
Review of current methods and future directions for detecting peptidic drugs in sports doping
- 07
Obesity drugs in clinical development
Curr Opin Investig Drugs / Curr Opin Investig Drugs
- 08
Survey of obesity drug candidates and therapeutics in clinical development pipeline
- 09
Gateways to clinical trials
Methods Find Exp Clin Pharmacol / Methods Find Exp Clin Pharmacol
- 10
Gateway approaches to clinical trial design and methodology
Compound
AOD-9604 compound data
- Formula
- C78H123N23O23S2
- Mol. weight
- 1815.1 g/mol
- PubChem CID
- 71300630 ↗
- IUPAC
- (2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-methyl-butanoyl]amino]-5-oxo-pentanoyl]amino]-13-(2-carboxyethyl)-22-(3-guanidinopropyl)-7,19-bis(hydroxymethyl)-16-isopropyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenyl-propanoic acid
FAQ
AOD-9604 questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone (HGH) specifically researched for its potential lipolytic (fat-burning) effects without the growth-promoting properties of full HGH.
How does AOD-9604 work?
HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.
Is AOD-9604 legal to buy?
AOD-9604 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy AOD-9604?
AOD-9604 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does AOD-9604 belong to?
AOD-9604 is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of AOD-9604?
AOD-9604 has been studied for: Fat metabolism, Lipolysis support, Body composition. HGH fragment focused on lipolysis.
News
AOD-9604 in the news
Peptide Therapy for Weight Loss: Separating Clinical Promise From Social Media Hype - Pharmacy Times
Pharmacy Times / 5 months ago
AOD 9604 Peptide: Expert Analysis Reviews Benefits and Side Effects for 2026 - Yahoo Finance
Yahoo Finance / 12 months ago
Should You Be Taking These? All 19 Controversial Peptides, Explained. - Men's Health
Men's Health / 23 days ago
The Peptide Craze - Ground Truths | Eric Topol
Ground Truths | Eric Topol / 16 months ago
AOD-9604 Peptide: Unlocking Its Potential in Metabolic and Regenerative Research - Health Tech World
Health Tech World / 18 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering AOD-9604?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.